We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aehr Test Systems | NASDAQ:AEHR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.13 | -1.12% | 11.48 | 11.26 | 11.62 | 11.55 | 11.26 | 11.36 | 448,194 | 00:03:16 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
____________________
(Exact name of registrant as specified in its charter) |
|
| |||
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
(Address of principal executive offices, including zip code) | ||||
| ||||
(Registrant’s telephone number, including area code) | ||||
| ||||
N/A | ||||
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
The |
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of shareholders of Aehr Test Systems (the “Company”) was held on October 23, 2023 (the “Annual Meeting”). There were 28,762,496 shares of common stock entitled to vote at the Annual Meeting and 20,958,389 shares were present in person or by proxy.
Four items of business were acted upon by the shareholders at the Annual Meeting. The final voting results are as follows:
Proposal One: Election of Directors of the Company.
|
| VOTES |
|
| VOTES |
|
| BROKER |
| |||
NOMINEE |
| FOR |
|
| WITHHELD |
|
| NON-VOTES |
| |||
Rhea J. Posedel |
|
| 9,001,500 |
|
|
| 5,779,054 |
|
|
| 6,177,835 |
|
Gayn Erickson |
|
| 14,713,089 |
|
|
| 67,465 |
|
|
| 6,177,835 |
|
Fariba Danesh |
|
| 14,554,341 |
|
|
| 226,213 |
|
|
| 6,177,835 |
|
Laura Oliphant |
|
| 13,636,198 |
|
|
| 1,144,356 |
|
|
| 6,177,835 |
|
Geoffrey G. Scott |
|
| 14,179,262 |
|
|
| 601,292 |
|
|
| 6,177,835 |
|
Howard T. Slayen |
|
| 14,259,600 |
|
|
| 520,954 |
|
|
| 6,177,835 |
|
Each of the six nominees was elected to serve as a director until the next Annual Meeting or until his or her successor is elected and qualified.
Proposal Two: Approve the adoption of the Company’s 2023 Equity Incentive Plan to replace the Company’s 2016 Equity Incentive Plan and provide a reserve for issuance of 1,500,000 shares of common stock of the Company.
|
| VOTES |
|
| VOTES |
|
| VOTES |
|
| BROKER |
| ||||
PROPOSAL |
| FOR |
|
| AGAINST |
|
| ABSTAIN |
|
| NON-VOTES |
| ||||
TWO |
|
| 12,542,957 |
|
|
| 996,473 |
|
|
| 1,241,124 |
|
|
| 6,177,835 |
|
The foregoing proposal was approved.
Proposal Three: Ratify the selection of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending May 31, 2024.
|
| VOTES |
|
| VOTES |
|
| VOTES |
|
| BROKER |
| ||||
PROPOSAL |
| FOR |
|
| AGAINST |
|
| ABSTAIN |
|
| NON-VOTES |
| ||||
THREE |
|
| 20,882,701 |
|
|
| 51,499 |
|
|
| 24,189 |
|
|
| - |
|
The foregoing proposal was accordingly ratified.
Proposal Four: Approve, on an advisory basis, the compensation of the Company’s named executive officers.
|
| VOTES |
|
| VOTES |
|
| VOTES |
|
| BROKER |
| ||||
PROPOSAL |
| FOR |
|
| AGAINST |
|
| ABSTAIN |
|
| NON-VOTES |
| ||||
FOUR |
|
| 13,520,292 |
|
|
| 1,172,122 |
|
|
| 88,140 |
|
|
| 6,177,835 |
|
The foregoing proposal was approved.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Aehr Test Systems |
| |
| (Registrant) |
| |
|
|
|
|
Date: October 25, 2023 | By: | /s/ Chris P. Siu |
|
|
| Chris P. Siu |
|
|
| Executive Vice President of Finance, |
|
|
| Chief Financial Officer and Secretary |
|
3 |
Cover |
Oct. 23, 2023 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | AEHR TEST SYSTEMS |
Entity Central Index Key | 0001040470 |
Document Type | 8-K |
Amendment Flag | false |
Entity Emerging Growth Company | false |
Document Period End Date | Oct. 23, 2023 |
Entity File Number | 000-22893 |
Entity Incorporation State Country Code | CA |
Entity Tax Identification Number | 94-2424084 |
Entity Address Address Line 1 | 400 Kato Terrace |
Entity Address City Or Town | Fremont |
Entity Address State Or Province | CA |
Entity Address Postal Zip Code | 94539 |
City Area Code | 510 |
Local Phone Number | 623-9400 |
Security 12b Title | Common Stock, par value $0.01 per share |
Trading Symbol | AEHR |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
1 Year Aehr Test Systems Chart |
1 Month Aehr Test Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions